113 related articles for article (PubMed ID: 16585098)
1. The sulphoxidation of S-carboxymethyl-L-cysteine in COPD.
Steventon GB; Mitchell SC
Eur Respir J; 2006 Apr; 27(4):865-6. PubMed ID: 16585098
[No Abstract] [Full Text] [Related]
2. The effect and mechanism of action of carbocysteine on airway bacterial load in rats chronically exposed to cigarette smoke.
Sun L; Tang L; Xu Y; Wang S; Li Y; Kang J
Respirology; 2010 Oct; 15(7):1064-71. PubMed ID: 20807377
[TBL] [Abstract][Full Text] [Related]
3. Efficacy of S-carboxymethyl-L-cysteine for otitis media with effusion.
Steventon GB; Mitchell SC
Ear Nose Throat J; 2006 May; 85(5):296-7. PubMed ID: 16771015
[No Abstract] [Full Text] [Related]
4. Diurnal variation in the metabolism of S-carboxymethyl-L-cysteine in humans.
Steventon GB
Drug Metab Dispos; 1999 Sep; 27(9):1092-7. PubMed ID: 10460812
[TBL] [Abstract][Full Text] [Related]
5. The role for S-carboxymethylcysteine (carbocisteine) in the management of chronic obstructive pulmonary disease.
Hooper C; Calvert J
Int J Chron Obstruct Pulmon Dis; 2008; 3(4):659-69. PubMed ID: 19281081
[TBL] [Abstract][Full Text] [Related]
6. The pharmacokinetics of orally administered S-carboxymethyl-L-cysteine in the dog, calf and sheep.
Panagopoulos P; Forbes B; Mitchell SC; Steventon GB
Eur J Pharm Sci; 2010 Feb; 39(4):219-23. PubMed ID: 20035864
[TBL] [Abstract][Full Text] [Related]
7. Carbocisteine for acute exacerbations of COPD.
Waller P; Suissa S
Lancet; 2008 Nov; 372(9650):1630; author reply 1631-2. PubMed ID: 18994655
[No Abstract] [Full Text] [Related]
8. A PEACE-ful solution to COPD exacerbations?
Albert P; Calverley P
Lancet; 2008 Jun; 371(9629):1975-6. PubMed ID: 18555897
[No Abstract] [Full Text] [Related]
9. Carbocisteine for acute exacerbations of COPD.
Mohapatra PR; Aggarwal D
Lancet; 2008 Nov; 372(9650):1630-1; author reply 1631-2. PubMed ID: 18994656
[No Abstract] [Full Text] [Related]
10. [Carbocysteine-sobrerol combination and exacerbation of chronic bronchitis].
Pasturenzi L; Donnetta AM; Gualtieri G; Luisetti M
Arch Monaldi Mal Torace; 1988; 43(6):487-505. PubMed ID: 3155012
[No Abstract] [Full Text] [Related]
11. Tracing the human metabolism of stable isotope-labelled drugs by ex vivo NMR spectroscopy. A revision of S-carboxymethyl-L-cysteine biotransformation.
Meese CO; Fischer P
Z Naturforsch C J Biosci; 1990; 45(11-12):1171-5. PubMed ID: 2095787
[TBL] [Abstract][Full Text] [Related]
12. Drug fever due to S-carboxymethyl-L-cystein: demonstration of a causative agent with patch tests.
Hatakeyama M; Fukunaga A; Shimizu H; Oka M; Horikawa T; Nishigori C
J Dermatol; 2012 Jun; 39(6):555-6. PubMed ID: 21950673
[No Abstract] [Full Text] [Related]
13. Exhaled Interleukine-6 and 8-isoprostane in chronic obstructive pulmonary disease: effect of carbocysteine lysine salt monohydrate (SCMC-Lys).
Carpagnano GE; Resta O; Foschino-Barbaro MP; Spanevello A; Stefano A; Di Gioia G; Serviddio G; Gramiccioni E
Eur J Pharmacol; 2004 Nov; 505(1-3):169-75. PubMed ID: 15556150
[TBL] [Abstract][Full Text] [Related]
14. Evaluation of the activity of the carbocysteine-sobrerol combination on mucus spinnability.
Distefano SM; Palermo F; Crimi N; Mistretta A; Pamparana F; Messa A
Int J Clin Pharmacol Res; 1988; 8(1):31-5. PubMed ID: 3284830
[TBL] [Abstract][Full Text] [Related]
15. Bronchial drainage prior to bronchography--a possible modification.
Nigam BK
Thorac Cardiovasc Surg; 1983 Feb; 31(1):49. PubMed ID: 6189253
[TBL] [Abstract][Full Text] [Related]
16. S-carboxymethyl-L-cysteine and it (R/S)-S-oxides in beagle dog plasma and hepatic cytosol.
Panagopoulos P; Mitchell SC; Steventon GB
Xenobiotica; 2015; 45(12):1047-53. PubMed ID: 26068525
[TBL] [Abstract][Full Text] [Related]
17. Carbocysteine: clinical experience and new perspectives in the treatment of chronic inflammatory diseases.
Macciò A; Madeddu C; Panzone F; Mantovani G
Expert Opin Pharmacother; 2009 Mar; 10(4):693-703. PubMed ID: 19239402
[TBL] [Abstract][Full Text] [Related]
18. [Guidelines of the German Respiratory League. Mucolytic drugs now also have a place in therapy of COPD].
MMW Fortschr Med; 2002 Sep; 144(38):60. PubMed ID: 12395714
[No Abstract] [Full Text] [Related]
19. [Antioxidative features of ambroxol--usefulness in COPD].
Nowak D
Pneumonol Alergol Pol; 2001; 69(9-10):590-3. PubMed ID: 11928667
[No Abstract] [Full Text] [Related]
20. Carbocisteine improves quality of life in patients with chronic obstructive pulmonary disease.
Tatsumi K; Fukuchi Y;
J Am Geriatr Soc; 2007 Nov; 55(11):1884-6. PubMed ID: 17979906
[No Abstract] [Full Text] [Related]
[Next] [New Search]
